Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylamine SCHEMBL2830556 | 0.78 | KMT2A (0.44) | KMT2AALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL10061827 | 0.77 | KMT2A (0.57) | KMT2AALDH1A1LMNAMAPTPOLB | |
| SCHEMBL11567424 | 0.76 | MAPT (0.43) | KMT2AALDH1A1LMNAMAPTHPGD | |
| SCHEMBL9293455 | 0.76 | CCNA2 (0.46) | KMT2AALDH1A1LMNAMAPTPOLB | |
| SCHEMBL28958798 | 0.76 | ALDH1A1 (0.55) | KMT2AALDH1A1LMNAMAPTPOLB | |
| SCHEMBL3492756 | 0.76 | TSHR (0.57) | KMT2AALDH1A1LMNAMAPTPOLB | |
| SCHEMBL20415330 | 0.76 | KMT2A (0.55) | KMT2AALDH1A1LMNAMAPTPOLB | |
| SCHEMBL28852641 | 0.74 | TSHR (0.43) | KMT2AALDH1A1LMNAMAPTPOLB | |
| SCHEMBL10904247 | 0.74 | KMT2A (0.53) | KMT2AALDH1A1LMNAMAPTPOLB | |
| SCHEMBL27954014 | 0.74 | ALDH1A1 (0.53) | KMT2AALDH1A1LMNAMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110357989-A | Tertiary amine photosensitizer, preparation method, comprising its photosensitive polymer combination and photosensitive polymer combination application | 常州强力电子新材料股份有限公司 | 2019-10-22 | — | — | CN | claimed |
| EP-2475687-B1 | A PHOTOINITIATOR COMPOSITION | SUN CHEMICAL BV (NL) | 2014-11-12 | — | — | EP | claimed |
| EP-0923597-B1 | SUBSTITUTED PROPARGYLETHOXYAMIDO NUCLEOSIDES | PE CORP NY (US) | 2001-09-26 | — | — | EP | claimed |
| US-5770716-A | CHAIN TERMINATING AND CHAIN EXTENDING NUCLEOTIDES, PRIMER EXTENSION REACTIONS, DNA SEQUENCING, POLYMERASE CHAIN REACTION | THE PERKIN-ELMER CORPORATION (US) | 1998-06-23 | — | — | US | claimed |
| JP-2161439-A | — | — | None | — | — | JP | disclosed |
| JP-2161440-A | — | — | None | — | — | JP | disclosed |
| CN-110357989-A | Tertiary amine photosensitizer, preparation method, comprising its photosensitive polymer combination and photosensitive polymer combination application | 常州强力电子新材料股份有限公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-103430100-B | Photosensitive resin composition, photoresist film using same, method for forming resist pattern, and method for forming conductor pattern | 日兴材料株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-104854199-A | Active energy ray curable offset ink composition | DIC GRAPHICS CORP | 2015-08-19 | — | — | CN | disclosed |
| US-20140155356-A1 | CURABLE BONE SUBSTITUTE | A ENTERPRISES, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| EP-2238105-B1 | NOVEL COMPOUNDS AS VANILLOID RECEPTOR ANTAGONISTS | AMOREPACIFIC CORP (KR) | 2014-04-16 | — | — | EP | disclosed |
| US-20140011881-A1 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2014-01-09 | — | — | US | disclosed |
| WO-1998045310-A1 | SUBSTITUTED PROPARGYLETHOXYAMIDO NUCLEOSIDES | THE PERKIN-ELMER CORPORATION (US) | 1998-10-15 | — | — | WO | disclosed |
| WO-1998045310-A1 | SUBSTITUTED PROPARGYLETHOXYAMIDO NUCLEOSIDES | THE PERKIN-ELMER CORPORATION (US) | 1998-10-15 | — | — | WO | disclosed |
| US-5770716-A | CHAIN TERMINATING AND CHAIN EXTENDING NUCLEOTIDES, PRIMER EXTENSION REACTIONS, DNA SEQUENCING, POLYMERASE CHAIN REACTION | THE PERKIN-ELMER CORPORATION (US) | 1998-06-23 | — | — | US | disclosed |
| US-5770716-A | CHAIN TERMINATING AND CHAIN EXTENDING NUCLEOTIDES, PRIMER EXTENSION REACTIONS, DNA SEQUENCING, POLYMERASE CHAIN REACTION | THE PERKIN-ELMER CORPORATION (US) | 1998-06-23 | — | — | US | disclosed |
| JP-H02161440-A | PHOTOPOLYMERIZABLE COMPOSITION | DAICEL CHEM IND LTD | 1990-06-21 | — | — | JP | disclosed |
| JP-H02161439-A | PHOTOSENSITIZER AND PHOTOPOLYMERIZABLE COMPOSITION | DAICEL CHEM IND LTD | 1990-06-21 | — | — | JP | disclosed |
| US-4133890-A | Hypolipidemic compositions and method employing derivatives of 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid | THE DOW CHEMICAL COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4105791-A | Hypolipidemic cycloalkylaminobenzoic acids | THE DOW CHEMICAL COMPANY (US) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011881-A1 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | TRPV1, TRPA1, TRPV2 | KMT2A 4592/4885ALDH1A1 787/4885LMNA 4285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.